Seizures in the critically ill
1Neurological Institute, Columbia University, New York, NY, USA.
Handbook of Clinical Neurology
|February 14, 2017
Summary
Critically ill patients experiencing seizures require prompt recognition and treatment to prevent severe outcomes like status epilepticus. Early antiepileptic drug administration is crucial for managing seizures in the ICU and improving patient survival.
Area of Science:
- Critical Care Medicine
- Neurology
- Neurocritical Care
Background:
- Critically ill patients in the ICU may develop seizures due to various factors including systemic illness, primary neurological conditions, or medication side effects.
- Seizures in this population can range from subtle symptoms to overt convulsive activity and may rapidly progress to status epilepticus.
- Status epilepticus (SE) in critically ill patients is associated with significant morbidity and mortality, often requiring complex management strategies.
Purpose of the Study:
- To highlight the challenges and critical importance of recognizing and treating seizures in critically ill patients.
- To emphasize the potential for seizures to escalate to status epilepticus (SE) in the intensive care unit (ICU) setting.
- To underscore the necessity of prompt intervention with antiepileptic drugs (AEDs) for favorable outcomes.
Main Methods:
- Review of clinical presentations and potential etiologies of seizures in critically ill patients.
- Discussion of the pathophysiology and complications of status epilepticus (SE) in the ICU.
- Emphasis on the diagnostic and therapeutic challenges in neurocritical care settings.
Main Results:
- Seizures in critically ill patients can be secondary to systemic or neurological issues and present with diverse symptoms.
- Untreated seizures can evolve into generalized convulsive or nonconvulsive status epilepticus (SE), carrying high mortality risks.
- Refractory SE may necessitate intensive treatments including anesthetics and narcotics.
Conclusions:
- Prompt recognition and initiation of antiepileptic drugs are paramount for successful treatment of status epilepticus (SE) in critically ill patients.
- Effective management of seizures in the ICU requires a high index of suspicion and rapid intervention.
- Attentiveness to seizure activity is critical for preventing severe neurological injury and improving survival rates in the neurocritical care setting.
Keywords:
antiepileptic drugcritically illnonconvulsive status epilepticuspharmacoresistantrefractory status epilepticusseizuresstatus epilepticusMore Related Videos
Related Concept Videos
Epilepsy and Seizures: Overview
1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Seizures: Classification
1.9K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Antiepileptic Drugs: Potassium Channel Activators
878
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
878
Electroconvulsive Therapy
1.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.6K
Antiepileptic Drugs: Calcium Channel Blockers
1.5K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.5K
Antiepileptic Drugs: Sodium Channel Blockers
2.1K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.1K


